Poster session 1
Antivirals

Programm

• • Poster Presentation
  • PP 001

  β-Cyclodextrins as affordable antivirals to treat coronavirus infection

  • Dr. Raquel Tenorio Vela (Madrid / ES)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 002

  Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2

  • Dr. Selina Pasquero (Turin / IT)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 003

  Iron oxide and iron oxyhydroxide nanoparticles impair influenza and SARS-CoV-2 infection

  • Dr. Marta L. DeDiego (Madrid / ES)

   Antivirals, One Health
• • Poster Presentation
  • PP 004

  In vitro efficacy testing of broad-spectrum antiviral agents Remdesivir, Molnupiravir and Favipiravir in combination with p38 MAPK inhibition against the human pathogenic Puumala orthohantavirus

  • Linah Chibrac-Ahad (Berlin / DE)

   Antivirals, Immune response to virus infection
• • Poster Presentation
  • PP 005

  Plitidepsin is a host-directed antiviral that transiently inhibits protein translation of distant viruses while shaping a protective proteostatic cellular response

  • Elisa Molina Molina (Rubí / ES)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 006

  Antiviral efficacy of far-UVC Radiation for application on human mucosa

  • Tom Lichtenthäler (Greifswald / DE)
  • Paula Zwicker (Greifswald / DE)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 007

  Metabolites isolated from Nostoc edaphicum are effective SARS-CoV2 entry inhibitors

  • Dr. Aleksandra Milewska (Cracow / PL)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 008

  Bridging the gap from fundamental virology to new antivirals

  • Dr. Andreas Kühbacher (Wuppertal / DE)

   Antivirals
• • Poster Presentation
  • PP 009

  A novel alternative strategy to combat the influenza virus – viral polymerase PA and PB1 subunits interaction inhibitors

  • Dr. Anna Bonomini (Padova / IT)

   Antivirals, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 010

  Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting the main protease Mpro

  • Greta Bajetto (Novara / IT)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 011

  Host target therapeutics as a broad-spectrum antiviral for medically important positive-sense RNA viruses

  • Dr. Thinesshwary Yogarajah (Singapore / SG)

   Antivirals, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 012

  Identification and characterization of novel SARS-CoV-2 inhibitors acting by different mechanisms

  • Dr. Alessandro Bazzacco (Padova / IT)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 013

  Development of infectious cell-based assays for the screening of small molecules targeting emerging viruses

  • Nathalie Gros (Montpellier / FR)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 014

  Glycopeptide antibiotic derivatives as lead compounds for new antivirals

  • Henrietta Papp (Pécs / HU)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 015

  Frog skin AMPs – promising antiviral peptides

  • Dr. Annalisa Chianese (Naples / IT)

   Antivirals, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 016

  Screening of peptides designed on Schmallenberg virus glycoproteins able to inhibit the viral infection

  • Dr. Carla Zannella (Naples / IT)

   Antivirals, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 017

  Insights into the antiviral activity of Hypericum perforatum extract and its ingredient hypericin

  • Fakry F. Mohamed (Muenster / DE)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 018

  Adaption of SARS-CoV-2 to mycophenolic acid-mediated depletion of intracellular GTP pools

  • Dr. Toni Luise Meister (Bochum / DE)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 019

  The association of depression among patients of hepatitis C virus taking direct antiviral agent

  • Fahad Mushtaq (Lahore / PK)

   Antivirals, One Health
• • Poster Presentation
  • PP 020

  Antiviral mechanism of silver nanoparticle-decorated graphene oxide nanomaterials – induction of immune response and membrane stress for early phase inhibition of HIV-1 infection

  • Soumajit Mukherjee (Brno / CZ)

   Antivirals, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 021

  R-propranolol has broad-spectrum anti-coronavirus activity and suppresses factors involved in pathogenic angiogenesis

  • Melissa Thaler (Leiden / NL)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 022

  NECESSITY – SARS-CoV-2 inhibitor development using crystallographic compound screening

  • Laila S. Benz (Berlin / DE)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 023

  Autoinhibition of suicidal capsid protease from O'nyong'nyong virus

  • Yuliya Chykunova (Kraków / PL)

   Antivirals, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 024

  Polyphenols epigallocatechin gallate, resveratrol and polyphenol-functionalized nanoparticles prevent enterovirus infection through clustering and stabilization of the viruses

  • Dhanik Reshamwala (Jyväskylä / FI)

   Antivirals
• • Poster Presentation
  • PP 025

  Importin a/b-dependent nuclear transport of human parvovirus B19 nonstructural protein 1 is essential for viral replication

  • Professor Gualtiero Alvisi (Padova / IT)

   Antivirals, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 026

  Effect of double combinations of antivirals against Coxsackievirus A9

  • Adelina Stoyanova (Sofia / BG)

   Antivirals
• • Poster Presentation
  • PP 027

  Comparative effectiveness of consecutive alternating administration of antivirals in Coxsackievirus B3 infection in mice

  • Adelina Stoyanova (Sofia / BG)

   Antivirals
• • Poster Presentation
  • PP 028

  Antiviral activity of Castalagin against herpes simplex virus 1 infection in mice

  • Adelina Stoyanova (Sofia / BG)

   Antivirals
• • Poster Presentation
  • PP 029

  Nitric oxide donor "NOD1" inhibits SARS-CoV-2 replication in vitro

  • Dario Akaberi (Uppsala / SE)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 030

  Hepatitis E virus signaling landscape identifies Yes1 as druggable host factor

  • Jil Alexandra Schrader (Bochum / DE)

   Antivirals, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 031

  Machine learning on large scale perturbation screens for SARS-CoV-2 host factors identifies β-catenin/CBP inhibitor PRI-724 as a potent antiviral

  • Maximilian A. Kelch (Frankfurt / DE)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 032

  Potential Chinese herbal medicines for dengue fever prevention – using national health insurance research database and bioassay for exploration

  • Wan-Yu Su (New Taipei City / TW)

   Antivirals
• • Poster Presentation
  • PP 033

  Intermittent therapy with IM-250, a helicase primase inhibitor, has persistent effects and may reduce the pool of latent reactivable herpes simplex virus

  • Prof. Dr. Gerald Kleymann (Munich / DE)

   Antivirals
• • Poster Presentation
  • PP 034

  Ultra potent multivalent neutralizing single-domain antibodies against Canine Distemper Virus

  • Melanie Scherer (Bern / CH)

   Antivirals, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 035

  Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings

  • Dr. Mihayl Varbanov (Vandœuvre-Lès-Nancy / FR)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 036

  A new and robust SARS-CoV-2 reporter replicon assay for anti-coronavirus drug discovery

  • Dr. Ilaria Carli (Pomezia Roma / IT)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 037

  Cross-neutralizing single-domain antibodies to fight Morbilliviruses

  • Akanksha A. Shanbhag (Bern / CH)

   Antivirals, Veterinary virology
• • Poster Presentation
  • PP 038

  Gold and silver nanoparticles functionalized with sulfonates or polyphenols – new drugs in treatment herpesviral infection

  • Dr. Marcin Chodkowski (Warsaw / PL)

   Antivirals, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 039

  Assessment of the effect of the formulation of PVA hydrogel with modified noble metal nanoparticles on the antiviral and immunomodulatory activity in herpesvirus type 1 and 2 infections

  • Professor Malgorzata Krzyzowska (Warsaw / PL)

   Antivirals, Immune response to virus infection
• • Poster Presentation
  • PP 040

  Broad-spectrum antiviral diazadispiroalkane core molecules block attachment and cell-to-cell spread of herpesviruses

  • Prof. Dr. Elke Bogner (Berlin / DE)

   Antivirals
• • Poster Presentation
  • PP 041

  Preclinical development of optimized DHODH inhibitors as broad-spectrum antivirals for the treatment of respiratory virus infections

  • A. Herrmann (Graefelfing / DE)

   Antivirals